Long-term Open-label Safety and Efficacy Study of Adalimumab in Subjects With Ulcerative Colitis
Clinical trial NCT00573794 · COMPLETED
Trial details
- NCT number
- NCT00573794
- Sponsor
- AbbVie (prior sponsor, Abbott)
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2007-11-28
- Primary completion
- 2016-12-01
- Enrollment
- 592
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.